Loading viewer...
earnings
Format: PDF earnings
Gilead Sciences presents third quarter 2022 financial and operational results, including commercial performance across virology, oncology and other programs. The presentation discusses progress on key product candidates, clinical trial updates, and the impact of COVID-19 and Veklury on business operations.
earnings
59 Pages
earnings
57 Pages
CLP Holdings
Lam Research Q3 2020 Earnings Results April 2020
earningsearnings
20 Pages
Lam Research Corporation
JDE Peet's Half-Year Results 2021
earningsearnings
31 Pages
JDE Peet's N.V.